Logo image of SNBR

SLEEP NUMBER CORP (SNBR) Stock Fundamental Analysis

NASDAQ:SNBR - Nasdaq - US83125X1037 - Common Stock - Currency: USD

8.28  -0.12 (-1.43%)

After market: 8.28 0 (0%)

Fundamental Rating

1

Overall SNBR gets a fundamental rating of 1 out of 10. We evaluated SNBR against 122 industry peers in the Specialty Retail industry. Both the profitability and financial health of SNBR have multiple concerns. SNBR has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

SNBR had negative earnings in the past year.
SNBR had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: SNBR reported negative net income in multiple years.
SNBR had a positive operating cash flow in 4 of the past 5 years.
SNBR Yearly Net Income VS EBIT VS OCF VS FCFSNBR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

1.2 Ratios

The Return On Assets of SNBR (-2.57%) is worse than 63.93% of its industry peers.
SNBR has a Return On Invested Capital (4.30%) which is in line with its industry peers.
SNBR had an Average Return On Invested Capital over the past 3 years of 7.69%. This is below the industry average of 12.03%.
Industry RankSector Rank
ROA -2.57%
ROE N/A
ROIC 4.3%
ROA(3y)-0.04%
ROA(5y)6.8%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)7.69%
ROIC(5y)19.87%
SNBR Yearly ROA, ROE, ROICSNBR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 -60

1.3 Margins

With a Operating Margin value of 1.66%, SNBR perfoms like the industry average, outperforming 48.36% of the companies in the same industry.
In the last couple of years the Operating Margin of SNBR has declined.
SNBR has a better Gross Margin (60.25%) than 88.52% of its industry peers.
In the last couple of years the Gross Margin of SNBR has remained more or less at the same level.
Industry RankSector Rank
OM 1.66%
PM (TTM) N/A
GM 60.25%
OM growth 3Y-34.99%
OM growth 5Y-18.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.42%
GM growth 5Y-0.76%
SNBR Yearly Profit, Operating, Gross MarginsSNBR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

0

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so SNBR is destroying value.
SNBR has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, SNBR has less shares outstanding
Compared to 1 year ago, SNBR has a worse debt to assets ratio.
SNBR Yearly Shares OutstandingSNBR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
SNBR Yearly Total Debt VS Total AssetsSNBR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

SNBR has an Altman-Z score of 0.25. This is a bad value and indicates that SNBR is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.25, SNBR is not doing good in the industry: 81.15% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.25
ROIC/WACC0.48
WACC8.98%
SNBR Yearly LT Debt VS Equity VS FCFSNBR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

2.3 Liquidity

SNBR has a Current Ratio of 0.19. This is a bad value and indicates that SNBR is not financially healthy enough and could expect problems in meeting its short term obligations.
SNBR has a worse Current ratio (0.19) than 97.54% of its industry peers.
SNBR has a Quick Ratio of 0.19. This is a bad value and indicates that SNBR is not financially healthy enough and could expect problems in meeting its short term obligations.
SNBR's Quick ratio of 0.08 is on the low side compared to the rest of the industry. SNBR is outperformed by 97.54% of its industry peers.
Industry RankSector Rank
Current Ratio 0.19
Quick Ratio 0.08
SNBR Yearly Current Assets VS Current LiabilitesSNBR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 37.50% over the past year.
The Revenue for SNBR has decreased by -12.35% in the past year. This is quite bad
SNBR shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.19% yearly.
EPS 1Y (TTM)37.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-15.15%
Revenue 1Y (TTM)-12.35%
Revenue growth 3Y-8.34%
Revenue growth 5Y-0.19%
Sales Q2Q%-16.41%

3.2 Future

Based on estimates for the next years, SNBR will show a very strong growth in Earnings Per Share. The EPS will grow by 36.29% on average per year.
SNBR is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.23% yearly.
EPS Next Y56.65%
EPS Next 2Y55.63%
EPS Next 3Y42.99%
EPS Next 5Y36.29%
Revenue Next Year-10.58%
Revenue Next 2Y-3.44%
Revenue Next 3Y-0.82%
Revenue Next 5Y-0.23%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
SNBR Yearly Revenue VS EstimatesSNBR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B
SNBR Yearly EPS VS EstimatesSNBR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 4 6

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SNBR. In the last year negative earnings were reported.
SNBR is valuated rather expensively with a Price/Forward Earnings ratio of 21.79.
SNBR's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 37.64. SNBR is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 21.79
SNBR Price Earnings VS Forward Price EarningsSNBR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

100.00% of the companies in the same industry are more expensive than SNBR, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 2.09
SNBR Per share dataSNBR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
SNBR's earnings are expected to grow with 42.99% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y55.63%
EPS Next 3Y42.99%

More info and screens

0

5. Dividend

5.1 Amount

SNBR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SLEEP NUMBER CORP

NASDAQ:SNBR (7/25/2025, 8:25:57 PM)

After market: 8.28 0 (0%)

8.28

-0.12 (-1.43%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)04-30 2025-04-30/amc
Earnings (Next)07-30 2025-07-30/bmo
Inst Owners78.28%
Inst Owner Change-0.26%
Ins Owners7.03%
Ins Owner Change32.46%
Market Cap187.62M
Analysts48.89
Price Target6.63 (-19.93%)
Short Float %29.1%
Short Ratio9.68
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-721.69%
Min EPS beat(2)-1452.29%
Max EPS beat(2)8.9%
EPS beat(4)3
Avg EPS beat(4)-345.92%
Min EPS beat(4)-1452.29%
Max EPS beat(4)41.39%
EPS beat(8)4
Avg EPS beat(8)-162.76%
EPS beat(12)7
Avg EPS beat(12)-69.04%
EPS beat(16)8
Avg EPS beat(16)-59.14%
Revenue beat(2)0
Avg Revenue beat(2)-4.16%
Min Revenue beat(2)-5.22%
Max Revenue beat(2)-3.11%
Revenue beat(4)0
Avg Revenue beat(4)-4.52%
Min Revenue beat(4)-6.21%
Max Revenue beat(4)-3.11%
Revenue beat(8)1
Avg Revenue beat(8)-4.35%
Revenue beat(12)3
Avg Revenue beat(12)-2.76%
Revenue beat(16)4
Avg Revenue beat(16)-3.27%
PT rev (1m)0%
PT rev (3m)-44.29%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-19.44%
EPS NY rev (1m)0%
EPS NY rev (3m)3.41%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.33%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.37%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 21.79
P/S 0.12
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 2.09
EPS(TTM)-0.95
EYN/A
EPS(NY)0.38
Fwd EY4.59%
FCF(TTM)-1.24
FCFYN/A
OCF(TTM)-0.41
OCFYN/A
SpS70.83
BVpS-20.16
TBVpS-23.09
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.57%
ROE N/A
ROCE -39.51%
ROIC 4.3%
ROICexc 4.32%
ROICexgc 5%
OM 1.66%
PM (TTM) N/A
GM 60.25%
FCFM N/A
ROA(3y)-0.04%
ROA(5y)6.8%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)7.69%
ROIC(5y)19.87%
ROICexc(3y)7.72%
ROICexc(5y)20.02%
ROICexgc(3y)8.92%
ROICexgc(5y)24.22%
ROCE(3y)152.05%
ROCE(5y)421.6%
ROICexcg growth 3Y-45.92%
ROICexcg growth 5Y-20.82%
ROICexc growth 3Y-44.92%
ROICexc growth 5Y-20.21%
OM growth 3Y-34.99%
OM growth 5Y-18.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.42%
GM growth 5Y-0.76%
F-Score5
Asset Turnover1.92
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 6.17
Cap/Depr 29.51%
Cap/Sales 1.17%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.19
Quick Ratio 0.08
Altman-Z 0.25
F-Score5
WACC8.98%
ROIC/WACC0.48
Cap/Depr(3y)71.87%
Cap/Depr(5y)77.97%
Cap/Sales(3y)2.57%
Cap/Sales(5y)2.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)37.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-15.15%
EPS Next Y56.65%
EPS Next 2Y55.63%
EPS Next 3Y42.99%
EPS Next 5Y36.29%
Revenue 1Y (TTM)-12.35%
Revenue growth 3Y-8.34%
Revenue growth 5Y-0.19%
Sales Q2Q%-16.41%
Revenue Next Year-10.58%
Revenue Next 2Y-3.44%
Revenue Next 3Y-0.82%
Revenue Next 5Y-0.23%
EBIT growth 1Y-7.48%
EBIT growth 3Y-40.41%
EBIT growth 5Y-18.25%
EBIT Next Year253.84%
EBIT Next 3Y61.41%
EBIT Next 5Y51.25%
FCF growth 1Y20.84%
FCF growth 3Y-75.01%
FCF growth 5Y-51.09%
OCF growth 1Y-130.66%
OCF growth 3Y-55.11%
OCF growth 5Y-32.18%